Cannabis e Psicose: Uma Visão Geral da Relação
DOI:
https://doi.org/10.51338/rppsm.378Resumo
N/A
Downloads
Referências
Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des. 2012;18:4966-79. doi: 10.2174/138161212802884780. DOI: https://doi.org/10.2174/138161212802884780
Pearson NT, Berry JH. Cannabis and Psychosis Through the Lens of DSM-5. Int J Environ Res Public Health. 2019;16:41-9. doi:10.3390/ijerph16214149 DOI: https://doi.org/10.3390/ijerph16214149
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.5th ed. Washington: American Psychiatric Publishing; 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596
Noble MJ, Hedberg K, Hendrickson RG. Acute cannabis toxicity. Clin Toxicol. 2019;57:735–42. doi:10.108 0/15563650.2018.1548708 DOI: https://doi.org/10.1080/15563650.2018.1548708
Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. JAMA Psychiatry. 2016;73:292-7. doi: 10.1001/jamapsychiatry.2015.3278. DOI: https://doi.org/10.1001/jamapsychiatry.2015.3278
Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm Des. 2014;20:4112–8. doi:10.2174/13816128113199990620 DOI: https://doi.org/10.2174/13816128113199990620
Giordano GN, Ohlsson H, Sundquist K, Sundquist J, Kendler KS. The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study. Psychol Med. 2015;45:407-14. DOI: https://doi.org/10.1017/S0033291714001524
Wilson L, Szigeti A, Kearney A, Clarke M. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. Schizophr Res. 2018;197:78-86. doi: 10.1016/j.schres.2017.11.001. DOI: https://doi.org/10.1016/j.schres.2017.11.001
Rentero D, Arias F, Sánchez-Romero S, Rubio G, Rodríguez-Jiménez R. Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use. Adicciones. 2021;33:95-108. doi: 10.20882/adicciones.1251. DOI: https://doi.org/10.20882/adicciones.1251
Ksir C, Hart CL. Cannabis and psychosis: a critical overview of the relationship. Curr Psychiatry Rep. 2016;18:12. doi:10.1007/s11920-015-0657-y. DOI: https://doi.org/10.1007/s11920-015-0657-y
Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, et al. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2020;270:403–12. doi:10.1007/s00406-019-01068-z DOI: https://doi.org/10.1007/s00406-019-01068-z
Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68:555– 61. doi:10.1001/archgenpsychiatry.2011.5. DOI: https://doi.org/10.1001/archgenpsychiatry.2011.5
Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophr Bull. 2016;42:1262–9. doi:10.1093/schbul/ sbw003. DOI: https://doi.org/10.1093/schbul/sbw003
Foglia E, Schoeler T, Klamerus E, Morgan K, Bhattacharyya S. Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis. Psychol Med. 2017;47:1691–705. doi:10.1017/S0033291717000046. DOI: https://doi.org/10.1017/S0033291717000046
Reid S, Bhattacharyya S. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review. Psychiatry Res. 2019;280:112523. doi:10.1016/j. psychres.2019.112523. DOI: https://doi.org/10.1016/j.psychres.2019.112523
